The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis

The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis

BackgroundThis meta-analysis evaluates the efficacy and safety of amyloid-β (Aβ) targeted therapies for delaying cognitive deterioration in Alzheimer’s disease (AD).MethodsPubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify relevant studies published...

Full description

Bibliographic Details
Main Authors:	Jiaxuan Li, Xin Wu, Xin Tan, Shixin Wang, Ruisi Qu, Xiaofeng Wu, Zhouqing Chen, Zhong Wang, Gang Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Alzheimer’s disease cognitive impairment amyloid-β monoclonal antibody γ-secretase inhibitors BACE-1 inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2023.1257973/full

Similar Items

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01)

Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating β-secretase and γ-secretase and alleviating oxidative stress in HT-22 cells
by: Lou-yan Ma, et al.
Published: (2025-03-01)

Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
by: Shiveena Bhatia, et al.
Published: (2023-08-01)

Alzheimer’s Disease: Current and Future Treatments. A Review
by: Evelyn Chou
Published: (2014-05-01)

Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1
by: Courtney J. Mycroft-West, et al.
Published: (2021-04-01)

One Pot Synthesis of Micromolar BACE-1 Inhibitors Based on the Dihydropyrimidinone Scaffold and Their Thia and Imino Analogues
by: Jessica Bais, et al.
Published: (2020-09-01)

Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission
by: Tugce Munise Satir, et al.
Published: (2020-05-01)

Development and Structural Modification of BACE1 Inhibitors
by: Ting Gu, et al.
Published: (2016-12-01)

Alzheimer’s Disease: Background, Current and Future Treatments
by: Evelyn Chou
Published: (2014-06-01)

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
by: Michael F. Egan, et al.
Published: (2019-08-01)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
by: Ulf Neumann, et al.
Published: (2018-09-01)

BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer’s disease
by: Richa Arya, et al.
Published: (2024-09-01)

Therapeutic agents for Alzheimer’s disease: a critical appraisal
by: Marta Weinstock
Published: (2024-12-01)

he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments
by: I. V. Litvinenko, et al.
Published: (2019-11-01)

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
by: Ruyue Zheng, et al.
Published: (2020-11-01)

The Large Ectodomain of APP Prevents APP from being Directly Cleaved by γ-Secretase
by: Yuan Li, et al.
Published: (2024-02-01)

Generation and deposition of Aβ43 by the virtually inactive presenilin‐1 L435F mutant contradicts the presenilin loss‐of‐function hypothesis of Alzheimer's disease
by: Benedikt Kretner, et al.
Published: (2016-03-01)

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct
by: Yong Ran, et al.
Published: (2017-05-01)

Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy
by: Maryam Ghanbari-Movahed, et al.
Published: (2021-02-01)

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
by: Maarten Timmers, et al.
Published: (2018-08-01)

Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling
by: Katarzyna Marta Zoltowska, et al.
Published: (2024-07-01)

A Glycosaminoglycan Extract from <i>Portunus pelagicus</i> Inhibits BACE1, the β Secretase Implicated in Alzheimer’s Disease
by: Courtney J. Mycroft-West, et al.
Published: (2019-05-01)

Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation
by: Mihaly eHajos, et al.
Published: (2013-06-01)

Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
by: Gunnar Nordvall, et al.
Published: (2023-10-01)

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
by: Jennifer A. Zimmer, et al.
Published: (2021-01-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Editorial: Plant-based bioactive compounds: natural tumor prevention?
by: Hui Jia, et al.
Published: (2023-10-01)

Implications of Microorganisms in Alzheimer’s Disease
by: Pardeep Yadav, et al.
Published: (2022-09-01)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
by: Judite R. M. Coimbra, et al.
Published: (2018-05-01)

Modelling Alzheimer’s disease: from past to future
by: Claudia eSaraceno, et al.
Published: (2013-06-01)

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
by: Wenxue Wu, et al.
Published: (2023-11-01)

Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties
by: Caterina Pont, et al.
Published: (2024-07-01)

Molecular mechanism of the intramembrane cleavage of the β-carboxyl terminal fragment of amyloid precursor protein by γ-secretase
by: Maho eMorishima-Kawashima
Published: (2014-11-01)

Changes in Aβ42, Neprilysin, and γ-Secretase in the Hippocampus of Male Rats Alzheimer’s model: The Effects of Aerobic Training and Omega-3 Intake
by: Ali Yaghoubi
Published: (2023-06-01)

Insights from Drosophila melanogaster model of Alzheimer's disease
by: Nguyen Trong Tue, et al.
Published: (2020-01-01)

Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review
by: Nachiket Jitendra Joshi, et al.
Published: (2024-01-01)

Multitarget drugs as potential therapeutic agents for alzheimer’s disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors
by: Pedro González-Naranjo, et al.
Published: (2022-12-01)

Interaction Prediction on BACE-1 Inhibitors Data for Alzheimer Disease using Message Passing Neural Network
by: Bihter Daş, et al.
Published: (2025-02-01)

The Role of Cholesterol in Amyloidogenic Substrate Binding to the γ-Secretase Complex
by: Urszula Orzeł, et al.
Published: (2021-06-01)

Prophylactic evaluation of verubecestat on disease‐ and symptom‐modifying effects in 5XFAD mice
by: Adrian L. Oblak, et al.
Published: (2022-01-01)